4
Changes in Ownership
Schrodinger, Inc. Filed Acc 0001628280-24-008959
Options or other derivatives
- President of R&D, Therapeutics acquired 120,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Akinsanya Karen President of R&D, Therapeutics | 2024-03-04 | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | D | ||
Loading xslF345X05/wk-form4_1709675058.xml…